About Ming Wai Lau Centre for Reparative Medicine

Ming Wai Lau Centre for Reparative Medicine is established to further accelerate research in stem cell biology, biomedical engineering, biotechnology, and regenerative medicine. With strong focus on technologies, a hub is being developed in Hong Kong to provide support and encouragement for increased research and innovation opportunities and further to strengthen the scientific interactions between Hong Kong and Karolinska Institutet.

Ming Wai Lau Centre for Reparative Medicine at Karolinska Institutet (MWLC) consists of two units, one in Stockholm and one in Hong Kong. The focus of the Hong Kong unit, which is established at the Hong Kong Science Park, will be on establishing a technology hub exploring novel technologies, including genome editing, reprogramming, single cell transcriptomics, biomedical engineering, and 3D tissue imaging technologies.

Three group leaders, at the Assistant Professor level, have been recruited to the Hong Kong unit. These are Sijie Chen, Linxian Li and Zongli Zheng. They will start their employments in February 2017.

The Stockholm unit encompasses a career support program for the most promising junior group leaders at Karolinska Institutet in the broad subject of reparative medicine and who are pursuing outstanding research in subjects related to the field. The first six Lau grant recipients was appointed in September 2016.

Finally, MWLC will establish a vibrant course program with research courses, workshops, and seminars at both the Stockholm and Hong Kong nodes, to further enhance interactions between the Karolinska Institutet and Hong Kong, and to create a vivid platform for synergistic collaborations.


The governing body of the MWLC consists of the steering group (see below).

Management team: Scientific Director Ola Hermanson; Administrative Director Marie Tell; Centre Coordinator Agneta Wallin Levinovitz; Director, Hong Kong node Ronald Li; Head of Administration, Hong Kong node Emily Ip.

Steering group

The steering group members are selected by the Vice Chancellor of Karolinska Institutet and they are: Deputy Vice-Chancellor for International Affairs at Karolinska Institutet, professor Maria Masucci (Chair); Dean of Research at Karolinska Institutet, professor Anders Gustafsson; Representative from the host institution, Deputy University Director Marie Tell; Donor, Mr. Ming Wai Lau; and Representative from Hong Kong University, Professor Paul Tam. The Scientific Director of MWLC, Dr Ola Hermanson is an adjunct member.


The donor Mr. Ming Wai Lau is the Chairman of Chinese Estates Holdings Ltd and Vice Chairman of the Bauhinia Foundation Research Centre. He holds a Master of Laws and a PhD from the London School of Economics and King’s College London, with his doctoral thesis being published as a book by Oxford University Press in 2011. He is also a registered attorney in the State of New York and is currently a visiting lecturer at Harvard Law School, Boston, USA. Ming Wai Lau is also active in public affairs.


Agneta Wallin Levinovitz, Centre Coordinator
E-mail: agneta.wallin.levinovitz@ki.se
Phone: +46-8-524 873 31

Emily Ip, Head of Administration (HK)
E-mail: emily.ip@ki.se
Phone: +852-2624-3807


CentreRegenerative MedicineStem Cell Biology